Givosiran
ALN-AS1-002
Phase 2 small_molecule completed
Quick answer
Givosiran for Acute Intermittent Porphyria is a Phase 2 program (small_molecule) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Acute Intermittent Porphyria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed